SISI.OTC.PinkShineco, INC

10-Q: Shineco Inc. Reports Q2 2025 Results: Revenue Up, Losses Persist Amid Reverse Stock Split

Sentiment:

Quarterly Report


Shineco Inc.'s Q2 2025 results show increased revenue but continued net losses, alongside a reverse stock split and ongoing efforts to address internal control weaknesses.

Capital raiseOn June 20, 2024, the Company entered into a securities purchase agreement with certain non-U.S. investors for gross proceeds of up to US$7.0 million.On July 11, 2024, the Company entered into an Underwriting Agreement with EF Hutton LLC for aggregate gross proceeds of approximately US$2.0 million.On August 22, 2024, the Company entered into a securities purchase agreement with 22 purchasers for an aggregate purchase price of US$8,241,750.On December 24, 2024, the Company entered into a securities purchase agreement with nine non-U.S. investors for gross proceeds of US$32.7 million.
Worse than expectedDespite increased revenue, the company continues to experience net losses.The company's working capital remains negative.The company's ability to continue as a going concern is dependent on continued financial support from its stockholders.

Summary

  • Shineco Inc. reported an increase in revenue for the six months ended December 31, 2024, reaching $5.22 million compared to $3.95 million in the same period of 2023.
  • Despite the revenue growth, the company experienced a net loss from continuing operations of $4.85 million, a slight improvement from the $8.57 million loss in the prior year.
  • The company implemented a 1-for-24 reverse stock split effective November 12, 2024.
  • The report identifies material weaknesses in internal control over financial reporting, including a lack of U.S. GAAP expertise, segregation of duties, and inadequate loan approval procedures.
  • Management is taking steps to address these weaknesses, including hiring qualified professionals and implementing stricter control policies.
  • The company's ability to continue as a going concern is dependent on continued financial support from its stockholders.
  • The company has taken actions to enhance liquidity, including securities purchase agreements and public offerings.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While revenue increased, the company continues to experience net losses and faces challenges related to internal controls and going concern. The active steps to raise capital and address weaknesses provide some positive signals, but the overall outlook remains uncertain.

Positives

  • Revenue increased by 32.15% to $5.22 million.
  • Net loss from continuing operations improved by 43.43% to $4.85 million.
  • General and administrative expenses decreased by 40.12% due to various factors including the settlement of a legal case.
  • The company is actively addressing material weaknesses in internal control over financial reporting.
  • The company has borrowed additional loans of approximately US$ 2.1 million from United Overseas Bank and renewed two short-term bank loans amounting to approximately US$ 1.8 million upon maturity.

Negatives

  • The company continues to experience net losses from continuing operations.
  • There are material weaknesses in internal control over financial reporting.
  • The company had negative working capital of $5.96 million as of December 31, 2024.
  • The company's ability to continue as a going concern is dependent on continued financial support from its stockholders.

Risks

  • The company's ability to continue as a going concern is dependent on continued financial support from its stockholders.
  • Material weaknesses in internal control over financial reporting could lead to misstatements in financial reporting.
  • Failure to maintain compliance with Nasdaq listing requirements could result in delisting.
  • The company's operations are subject to political, economic, and legal risks associated with operating in the PRC.

Future Outlook

The company's future performance depends on increasing demand for its products, maintaining effective cost control, and managing economic and political risks. The company intends to develop new products, expand its distribution network, and grow through potential mergers and acquisitions.

Industry Context

The company operates in the health and well-being sector, with a focus on plant-based products, rapid diagnostic products, and healthy meals. The company's performance is influenced by factors such as consumer demand for health-oriented products, competition in the agricultural and healthcare industries, and regulatory changes in the PRC.

Related Party Transactions

  • The Company made sales of US$ 678,142 to its related party, Chongqing Fuling District Renyi Zhilu Silk Industry Co., Ltd, for the six months ended December 31, 2024.
  • The Companys related parties provide a guarantee for the Companys bank loans.
  • Chongqing Wintus (New Star) Enterprises Group provided a guarantee that amounted to US$ 685,076 for a bank loan borrowed by Chongqing Yufan, a related party of the Company until December 28, 2025.
  • The Company entered into a two-year lease agreement for the lease of office space from a related party company, of which the CEO is the Companys shareholder.

Stakeholder Impact

  • Shareholders: The reverse stock split and continued losses may negatively impact shareholder value.
  • Employees: The company's cost control measures may impact employee compensation and job security.
  • Customers: The company's focus on developing new products and expanding its distribution network may benefit customers by providing access to a wider range of products and services.
  • Creditors: The company's ability to repay its debts is dependent on its ability to generate revenue and raise capital.

Next Steps

  • The company intends to use approximately 50% of the net proceeds from the Offering for mergers and acquisitions, approximately 25% for repaying outstanding convertible notes, and 25% for general corporate purposes.
  • The company plans to gradually establish additional branches in key cities across China, including Beijing, Shanghai, Guangzhou, and other southeastern coastal regions.

Key Dates

DateDescription
1997-08-20Shineco, Inc. was incorporated in the State of Delaware.
2003-12-15Tenet-Jove was incorporated under the laws of China.
2004-12-30The Company acquired all of the issued and outstanding shares of Beijing Tenet-Jove Technological Development Co., Ltd.
2006-07-14Tenet-Jove was officially granted the status of a wholly foreign-owned entity by Chinese authorities.
2016-09-28The Company completed its initial public offering.
2020-07-10The Companys stockholders approved a 1-for-9 reverse stock split.
2020-08-14Market effective date of the 1-for-9 reverse stock split.
2021-06-08Tenet-Jove entered into a Restructuring Agreement with various parties.
2022-12-30Shineco Life closed the acquisition of 51% of the issued equity interests of Changzhou Biowin Pharmaceutical Co., Ltd.
2023-05-29Shineco Life entered into a stock purchase agreement with Dream Partner Limited, Chongqing Wintus Group, and certain shareholders of Dream Partner.
2023-07-31Acquisition date of Wintus.
2024-02-01The Companys stockholders approved a 1-for-10 reverse stock split.
2024-02-16Effective date of the 1-for-10 reverse stock split.
2024-06-20The Company entered into a securities purchase agreement with certain non-U.S. investors.
2024-07-11The Company entered into an Underwriting Agreement with EF Hutton LLC.
2024-07-15The Offering closed.
2024-08-22The Company entered into a securities purchase agreement with 22 purchasers.
2024-09-10The closing of the transaction contemplated by the SPA took place.
2024-10-21The Companys stockholders approved a 1-for-24 reverse stock split.
2024-11-12Effective date of the 1-for-24 reverse stock split.
2024-12-24The Company entered into a securities purchase agreement with nine non-U.S. investors.
2025-01-10The December 2024 Shares were issued to the December 2024 Purchasers.
2025-02-06The Company entered into a loan agreement with Bank of China.
2025-02-10The Company entered into a loan agreement with Chongqing Rural Commercial Bank.
2025-02-14Date of report approval by management.

Keywords

financial results, reverse stock split, internal control, going concern, Shineco, revenue, losses

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.